Could a single infusion of supercharged immune cells let HIV patients ditch daily pills?

NCT ID NCT04648046

First seen May 02, 2026 · Last updated May 14, 2026 · Updated 2 times

Summary

This study tests a new treatment for HIV that uses a person's own immune cells, modified to better recognize and attack the virus. About 18 adults with well-controlled HIV will receive these special cells, and then temporarily stop their regular HIV medications to see if the treatment can keep the virus in check. The goal is to find a safe dose and see if this approach can control HIV without daily pills.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of California, Davis

    RECRUITING

    Sacramento, California, 95817, United States

    Contact Email: •••••@•••••

    Contact

  • Zuckerberg San Francisco General

    RECRUITING

    San Francisco, California, 94110, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.